Given the cross-sectional character of our study the pathogenesis of the reduced superficial perfusion density remains unclear but a possible explanations might include a vasoconstrictor effect of anti-VEGF therapy with immediate effect upon the first injection as well as a characteristic of AMD itself. The gene discussed is VEGFA; the disease is age-related macular degeneration.